LCN2 and chronic kidney disease: We expect that we will further improve the predictive ability of urine output by the combination of patient-specific variables (e.g., CRRT duration, CKD status), biomarkers (e.g., CysC, NGAL, kinetic eGFR), and clinical severity scores (e.g., SOFA score, APACHE II score).